Skip to main content
. Author manuscript; available in PMC: 2008 Nov 1.
Published in final edited form as: J Ren Nutr. 2007 Nov;17(6):397–407. doi: 10.1053/j.jrn.2007.06.001

Table 1.

Clinical characteristics of two groups of hemodialysis patients: those receiving active vitamin D (1,25 (OH)2D and those not receiving any form of active vitamin D

Characteristics Receiving
1,25 (OH)2 D or analog (n = 49)
Not Receiving
1,25 (OH)2 D or analog (n = 30)
P
value
Age, years 49 55 ± 1.8 30 56 ± 2.5 0.83
Gender 49 31 M (63%) / 18 F 30 19 M (63%) / 11 F 0.99
Race/ethnicity n (%) 49 30 0.59
 African American 20 (60%) 17 (58%)
 Filipino 7 (15%) 3 (10%)
 Asian 7 (15%) 3 (10%)
 Hispanic 4 (8%) 5 (16%)
 Caucasian 1 (2%) 2 (6%)
Body Weight kg 49 75.5 ± 3.2 30 74.6 ± 3.4 0.85
BMI, kg/m2 49 28 ± 1 30 26 ± 1 0.37
Comorbid Conditions n (%) 49 30
 Hypertension 45 (93%) 28 (93%) 0.80
 Diabetes Mellitus 21 (43%) 18 (58%) 0.14
 Coronary Artery Disease 22 (45%) 13 (43%) 0.99
 Peripheral Vascular Disease 8 (17%) 2 (6%) 0.21
Dialysis Vintage, months** 49 25 (3, 288) 30 30 (4, 152) 0.98
Kt/V 49 1.37 ± 0.04 29 1.46 ± 0.27 0.20
Serum albumin, mg/dL 49 4.00 ± 0.06 29 3.79 ± 0.09 0.04
Hemoglobin g/dL 49 11.9 ± 0.2 29 11.8 ± 0.3 0.95
Serum urea nitrogen, mmol/L (mg/dL) 49 21± 0.7 (59 ± 2.0) 29 22 ± 1.2 (63 ± 3.5) 0.29
Serum creatinine, μmol/L (mg/dL) 49 887.6 ± 37.7 (10.0 ± 0.4) 28 936.1 ± 48.8 (10.6 ± 0.6) 0.38
Serum calcium, mmol/L (mg/dL) 49 2.31 ± 0.02 (9.2 ± 0.09) 29 2.27 ± 0.05 (9.1 ± 0.18) 0.60
Serum phosphorous, mmol/L(mg/dL), 49 1.99 ± 0.11 (6.2 ± 0.3) 29 1.81 ± 0.10 (5.6 ± 0.3) 0.27
Serum alkaline phosphatase, units/L 48 134 ± 26 28 115 ± 12 0.66
Intact parathyroid hormone, ng/L (pg/ml)** 43 309 (56,1482) 24 230 (37,1435) 0.26

Laboratory results reported in SI units with conventional units in parentheses. Data presented as the mean ± SEM except ** which are reported as the median (minimum,maximum) because of non-normal distribution